What podcasts say about Sanofi
Every statement, with the speaker, the exact quote and the moment it was said.
What experts have said about Sanofi
6 statements · 1 positive · 5 negative
Sanofi will need to replace income when the prior drug patent expires in the early 2030s.
“when that patent begins to expire in early 2030s, they then need to replace that income.”
Open the episode · AG Barr Drops, LandSec Falls, Sanofi GainsListen at 4:19
Sanofi shares rose about 3.7% in Paris after the partnership news.
“shares rising on the back of that, they're up about 3.7% in Paris.”
Open the episode · AG Barr Drops, LandSec Falls, Sanofi GainsListen at 4:27
Sanofi needs to expand its drug pipeline further.
“intensifies that need for that pipeline to be built out more”
Open the episode · SAP Beats, Sanofi Dips, Arcadis GainsListen at 2:50
Sanofi’s pipeline weakness may increase pressure for more acquisitions.
“it also therefore potentially raises the pressure on her to pursue a more of an M and A approach”
Open the episode · SAP Beats, Sanofi Dips, Arcadis GainsListen at 2:54
Sanofi halted a late-stage trial of an experimental drug for a rare autoimmune disorder.
“it just halted a late stage trial for an experimental drug for a rare autoimm disorder”
Open the episode · WH Smith Cuts, Sanofi Setback, STMicro UpListen at 2:33
Sanofi’s late-stage trial produced disappointing results.
“the lays take trial disappointed there”
Open the episode · WH Smith Cuts, Sanofi Setback, STMicro UpListen at 2:48
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.